1. Home
  2. AORT vs PRCT Comparison

AORT vs PRCT Comparison

Compare AORT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$43.48

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$30.54

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AORT
PRCT
Founded
1984
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.8B
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
AORT
PRCT
Price
$43.48
$30.54
Analyst Decision
Strong Buy
Buy
Analyst Count
5
9
Target Price
$49.36
$51.13
AVG Volume (30 Days)
304.0K
1.1M
Earning Date
02-23-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$422,646,000.00
$299,907,000.00
Revenue This Year
$15.97
$48.30
Revenue Next Year
$10.96
$29.44
P/E Ratio
N/A
N/A
Revenue Growth
9.81
50.07
52 Week Low
$21.97
$27.80
52 Week High
$48.25
$79.29

Technical Indicators

Market Signals
Indicator
AORT
PRCT
Relative Strength Index (RSI) 40.55 41.81
Support Level $41.82 $29.62
Resistance Level $45.99 $35.20
Average True Range (ATR) 1.38 1.60
MACD -0.28 -0.29
Stochastic Oscillator 33.07 15.92

Price Performance

Historical Comparison
AORT
PRCT

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: